But the new observational study (Abuse Rates and Routes of Administration of Reformulated Extended-Release Oxycodone: Initial Findings From a Sentinel Surveillance Sample of Individuals Assessed for Substance Abuse Treatment), suggests a breakthrough.

FORBES: Is The Era Of OxyContin Abuse Over?

The 5% sample was too small to allow a detailed analysis of the treatment patterns of distinct urology groups.

WSJ: How The Wall Street Journal Crunched the Medicare Numbers